MERISTEM THERAPEUTICS Trademark

Trademark Overview


On Wednesday, September 23, 1998, a trademark application was filed for MERISTEM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MERISTEM THERAPEUTICS trademark a serial number of 75557320. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 25, 2012. This trademark is owned by BIOCEM. The MERISTEM THERAPEUTICS trademark is filed in the Chemical Products, Cosmetics & Cleaning Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

[ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic regents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]

[ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and celluloses, all obtained from plants ]

[ Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency...

Scientific and industrial research, namely, biotechnology research on chemical products intended for industry, science, photography, agriculture, horticulture, forestry, on pharmaceutical or cosmetic proteins obtained from plants, on pharmaceutical products, veterinary products, hygiene products within the pharmaceutical field, on dietary products for children, on biotechnology products obtained from plants; biological and biotechnological services, namely, genetic modification of plants and plant cells, embryos, cals, seeds, pollen leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, and field trial...
meristem therapeutics

General Information


Serial Number75557320
Word MarkMERISTEM THERAPEUTICS
Filing DateWednesday, September 23, 1998
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 25, 2012
Registration Number2499316
Registration DateTuesday, October 23, 2001
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 31, 2001

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Services[ Chemicals for use in the manufacture of photographic materials, namely, dyes, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, cosmetics, glues and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil conditioners, fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, and proteins, namely, plant and animal and microbial growth hormones, growth regulators and inhibitors, diagnostic regents, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers ]
Goods and Services[ Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or immunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and celluloses, all obtained from plants ]
Goods and Services[ Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely, human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies ]
Goods and ServicesScientific and industrial research, namely, biotechnology research on chemical products intended for industry, science, photography, agriculture, horticulture, forestry, on pharmaceutical or cosmetic proteins obtained from plants, on pharmaceutical products, veterinary products, hygiene products within the pharmaceutical field, on dietary products for children, on biotechnology products obtained from plants; biological and biotechnological services, namely, genetic modification of plants and plant cells, embryos, cals, seeds, pollen leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, and field trials of genetically modified plants; expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biotechnology laboratories; engineering work and research and development in plant biotechnology
Lining/Stippling StatementTHE WORD "MERISTEM" IN THE MARK APPEARS IN BLUE, THE WORD "THERAPEUTICS" IN THE MARK APPEARS IN GREEN, THE GRAPHIC ON THE FAR LEFT OF THE MARK CONTAINING THE STYLIZED BRANCH DEPICTION IS A COLORLESS BRANCH ON A GREEN BACKGROUND WITH A DARKER GREEN SHADOW APPEARING UNDER THE BRANCH, THE CIRCULAR GRAPHIC IN THE CENTER OF THE MARK CONTAINING THE STYLIZED DNA DEPICTION IS A COLORLESS HELICAL DESIGN ON A BLUE BACKGROUND WITH A DARKER BLUE SHADOW APPEARING UNDER THE HELICAL DESIGN, AND THE GRAPHIC APPEARING AT THE RIGHT OF THE MARK CONTAINING THE STYLIZED HUMAN FIGURE IS A COLORLESS HUMAN FIGURE ON A LIGHT ORANGE BACKGROUND WITH A RED SHADOW APPEARING UNDER THE HUMAN FIGURE.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 25, 2012
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 25, 2012
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 25, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 25, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMERISTEM THERAPEUTICS
Party Type31 - New Owner After Registration
Legal Entity Type09 - Joint Stock Company
AddressF-63000 CLERMONT-FERRAND
FR

Party NameBIOCEM
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address63170 Aubiere
FR

Party NameBIOCEM
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address63170 Aubiere
FR

Party NameBIOCEM
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address63170 Aubiere
FR

Trademark Events


Event DateEvent Description
Friday, May 25, 2012CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Monday, May 12, 2008REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, April 23, 2008REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, May 6, 2008ASSIGNED TO PARALEGAL
Wednesday, April 23, 2008TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 23, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 18, 2007CASE FILE IN TICRS
Tuesday, October 23, 2001REGISTERED-PRINCIPAL REGISTER
Tuesday, July 31, 2001PUBLISHED FOR OPPOSITION
Wednesday, July 18, 2001NOTICE OF PUBLICATION
Wednesday, February 14, 2001APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 22, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 31, 2000FINAL REFUSAL MAILED
Monday, November 15, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 11, 1999ASSIGNED TO EXAMINER
Monday, June 21, 1999NON-FINAL ACTION MAILED
Thursday, May 13, 1999NON-FINAL ACTION MAILED
Thursday, April 29, 1999ASSIGNED TO EXAMINER
Friday, April 23, 1999ASSIGNED TO EXAMINER